-- CB-010 ANTLER 2L LBCL Phase 1 dataset expected to include at least six months of follow up on the majority of patients; ongoing interactions with FDA on potential pivotal trial design -- -- CB-011 ...
BOSTON, July 25, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...
A recent organizational review of the Regional District of Central Kootenay has confirmed that the RDCK’s core challenges are ...
I’ve learned that limited resources are a clarifier, not a constraint. When two priorities matter equally, I choose the sequence that strengthens our foundation first—because that early focus creates ...
– Strategic restructuring includes reduced operating expenses, delivering approximately $400 million in anticipated annual cost savings, and implementing a 36% workforce reduction of approximately 500 ...
One leader at Blue Shield California shares the company's strategic priorities. Dr. Pushwaz Virk serves as the Medical Director of Clinical Product Development, Care Innovation, and Technology ...
The healthcare investor conference MedCity INVEST, scheduled for May 20-21 at the Willis Tower in Chicago, will spotlight strategic priorities for health systems at a time when many face uncertainty ...
In a recent discussion led by Mackenzie Bean, three panelists shared their perspectives on the strategic priorities of their respective healthcare organizations. These priorities include creating a ...
In the modern and accelerated world of high-stakes corporate projects, it’s easy to feel overwhelmed by constant demands and pressures. Everything seems urgent, every task appears to be priority one ...
MORRISTOWN, N.J.--(BUSINESS WIRE)--Majesco, a global leader in cloud insurance software solutions, today announced the release of its latest Thought Leadership report, Strategic Priorities 2025: A ...
Prioritizing autoimmune programs aims to focus upon near-term and intermediate value creation potential, while retaining oncology programs as promising clinical data continues to mature - Company ...